ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Fujifilm has acquired a 41% stake in Tokyo-listed Japan Tissue Engineering (J-Tec), a firm that aims to develop tissue-engineered medical materials. On the basis of J-Tec’s current stock price, Fujifilm’s acquisition is worth $47 million. The photographic-film maker says it has been researching the regeneration of malfunctioning tissues and organs on its own as a way to diversify its business, recognizing that digital technology is making its traditonal photographic-film business obsolete. Fujifilm expects that several more years of research are needed before the two firms can develop practical materials together.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter